Does PEMBROLIZUMAB Cause Pulmonary mass? 160 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 160 reports of Pulmonary mass have been filed in association with PEMBROLIZUMAB (KEYTRUDA). This represents 0.2% of all adverse event reports for PEMBROLIZUMAB.
160
Reports of Pulmonary mass with PEMBROLIZUMAB
0.2%
of all PEMBROLIZUMAB reports
20
Deaths
65
Hospitalizations
How Dangerous Is Pulmonary mass From PEMBROLIZUMAB?
Of the 160 reports, 20 (12.5%) resulted in death, 65 (40.6%) required hospitalization, and 8 (5.0%) were considered life-threatening.
Is Pulmonary mass Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PEMBROLIZUMAB. However, 160 reports have been filed with the FAERS database.
What Other Side Effects Does PEMBROLIZUMAB Cause?
Malignant neoplasm progression (10,111)
Death (4,744)
Diarrhoea (4,251)
Fatigue (3,833)
Off label use (3,416)
Product use in unapproved indication (3,191)
Pyrexia (3,155)
Rash (2,900)
Nausea (2,670)
Decreased appetite (2,486)
What Other Drugs Cause Pulmonary mass?
ADALIMUMAB (1,299)
METHOTREXATE (1,153)
PREDNISONE (755)
ALBUTEROL (736)
ETANERCEPT (665)
TIOTROPIUM (624)
RITUXIMAB (531)
BUDESONIDE\FORMOTEROL (464)
MEPOLIZUMAB (450)
LEFLUNOMIDE (430)
Which PEMBROLIZUMAB Alternatives Have Lower Pulmonary mass Risk?
PEMBROLIZUMAB vs PEMETREXED
PEMBROLIZUMAB vs PEMIGATINIB
PEMBROLIZUMAB vs PENICILLAMINE
PEMBROLIZUMAB vs PENICILLIN
PEMBROLIZUMAB vs PENICILLIN G